BSE filing, NSE: NH. Summary written from the filing by ALFA Finder's alert engine.
Narayana Hrudayalaya Ltd: key numbers
- Share price
- ₹1,720.00
- Market cap
- ₹35,150 Cr
- Revenue (annual)
- ₹7,896 Cr
- Net profit (annual)
- ₹805.6 Cr
- P/E (TTM)
- 43.1×Sector 51.1×
- Promoter holding
- 63.27%+0.00% QoQ
- FII holding
- 9.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Narayana Hrudayalaya Ltd
All →Narayana Hrudayalaya Board Meeting Date
Narayana Hrudayalaya will hold a board meeting on 30 October 2026 to consider unaudited results. Results are not yet approved.
Narayana Hrudayalaya Capacity Expansion
Narayana Hrudayalaya signed an agreement to operate and manage the Mission of Mercy Hospital in Kolkata. This expands its operational footprint by 100 hospital beds.
- hospital capacity
- 100.0 beds
Narayana Hrudayalaya Annual General Meeting
Narayana Hrudayalaya Limited announced the voting results and Scrutinizer's report for the postal ballot approving the revision in professional fee for Dr. Varun Shetty.
Narayana Hrudayalaya Legal & Regulatory
Narayana Hrudayalaya received a GST demand order from the Assistant Commissioner of Central Tax, imposing a penalty of ₹0.53 Crore. The company intends to file an appeal.
- Value
- ₹0.53 Cr
Narayana Hrudayalaya Other Announcement
Narayana Hrudayalaya Limited has relocated its corporate office to a new premises in Electronics City, Bengaluru, effective September 21, 2026.
Narayana Hrudayalaya Annual General Meeting
Narayana Hrudayalaya issued a postal ballot notice seeking shareholder approval for a revised professional fee of Rs. 4.80 crore per annum to Dr. Varun Shetty.
- Value
- ₹4.80 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.